Mboussou Franck, Mulumba Audry, Traore Celestin, Conteh-Nordman Florence, Ndoula Shalom Tchokfe, Mbailamen Antoinette Demian, Bizimana Jean Claude, Akani Christian, Vuo-Masembe Yolande, Farham Bridget, Nimpa Marcelin Menguo, Gaha Thomas Noel, Morand Martin, Rey Lynda, Danovaro-Holliday Maria Carolina, Wiysonge Charles Shey, Impouma Benido
World Health Organization Regional Office for Africa, Brazzaville P.O. Box 06, Congo.
Essential Immunization Programme, Ministry of Health, 30 Avenue de la Justice, Kinshasa M7MG+2X8, Democratic Republic of the Congo.
Vaccines (Basel). 2025 Mar 11;13(3):301. doi: 10.3390/vaccines13030301.
Since 1974, Essential Programme on Immunisation managers from ten Central African countries meet yearly with partners to review progress made and share experiences and lessons learned from the implementation of immunization programmes. The 2024 meeting occurred in Kinshasa, Democratic Republic of Congo, in September 2024. This conference report summarizes the key takeaways from discussions on using immunization data for decision-making, the implementation of the Big Catch-Up (BCU) initiative to reduce the burden of zero-dose children, and progress and challenges in introducing selected new vaccines. Conference Takeaways: Inaccurate administrative data on routine immunization observed in most countries, compared to WHO/UNICEF Estimates of National Immunization Coverage and national survey estimates, affect timely decisions to improve the Expanded Programme on Immunization (EPI) performance. Five countries in Central Africa are among the priority countries of the BCU initiative but, as of the end of August 2024, are yet to formally start its implementation. Cameroon and Central African Republic introduced the malaria vaccine in January 2024 and August 2024, respectively, while the Democratic Republic of Congo, Chad, and Burundi have planned to do so by 2025.
Meeting participants put forward several recommendations for countries and immunization partners, including but not limited to (i) investing more in routine immunization data quality assurance to better use data to inform decisions, (ii) accelerating the implementation of the BCU initiative to close the immunity gap resulting from routine immunization disruptions due to the COVID-19 pandemic, (iii) updating malaria vaccine introduction plans to invest more in demand generation and community engagement, and (iv) learning from Cameroon's experience in tackling hesitancy to human papilloma virus vaccine. It is critical to set up an appropriate mechanism for monitoring the implementation of these recommendations.
自1974年以来，来自十个中非国家的免疫规划核心管理人员每年都会与合作伙伴会面，以审查取得的进展，并分享免疫规划实施过程中的经验和教训。2024年的会议于2024年9月在刚果民主共和国金沙萨举行。本会议报告总结了关于利用免疫数据进行决策、实施“大追赶”（BCU）倡议以减轻零剂次儿童负担以及引进选定新疫苗的进展和挑战的讨论要点。会议要点：与世界卫生组织/联合国儿童基金会的国家免疫覆盖率估计数和国家调查估计数相比，大多数国家常规免疫的行政数据不准确，这影响了及时做出改善扩大免疫规划（EPI）绩效的决策。中非的五个国家是BCU倡议的重点国家，但截至2024年8月底，尚未正式启动该倡议的实施。喀麦隆和中非共和国分别于2024年1月和2024年8月引进了疟疾疫苗，而刚果民主共和国、乍得和布隆迪计划在2025年前引进。
与会者为各国和免疫合作伙伴提出了多项建议，包括但不限于：（i）加大对常规免疫数据质量保证的投入，以便更好地利用数据为决策提供信息；（ii）加快实施BCU倡议，以弥合因新冠疫情导致常规免疫中断而产生的免疫差距；（iii）更新疟疾疫苗引进计划，加大对需求生成和社区参与的投入；（iv）借鉴喀麦隆应对人乳头瘤病毒疫苗犹豫问题的经验。建立适当的机制来监测这些建议的实施至关重要。
